추천 제품
분석
>99% (TLC)
형태
powder
포장
pkg of 2 × 100 mg (840022P-200mg)
pkg of 1 × 25 mg (840022P-25mg)
제조업체/상표
Avanti Research™ - A Croda Brand 840022P
지질 유형
phosphoglycerides
배송 상태
dry ice
저장 온도
−20°C
SMILES string
[H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O
InChI
1S/C41H80NO8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-40(43)47-37-39(38-49-51(45,46)48-36-35-42)50-41(44)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h18,20,39H,3-17,19,21-38,42H2,1-2H3,(H,45,46)/b20-18-/t39-/m1/s1
InChI key
JQKOHRZNEOQNJE-DJEJVYNPSA-N
일반 설명
Contains ~50% plasmalogen ether lipid
애플리케이션
Brain PE has been used for the preparation of liposomes.
포장
5 mL Clear Glass Sealed Ampule (840022P-200mg)
5 mL Clear Glass Sealed Ampule (840022P-25mg)
법적 정보
Avanti Research is a trademark of Avanti Polar Lipids, LLC
Storage Class Code
11 - Combustible Solids
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
이미 열람한 고객
Saurabh Srivastava et al.
PloS one, 10(6), e0130283-e0130283 (2015-06-20)
Recent studies introduced two experimental protocols for converting full-length recombinant prion protein (rPrP) purified from E.coli into the infectious prion state (PrPSc) with high infectivity titers. Both protocols employed protein misfolding cyclic amplification (PMCA) for generating PrPSc de novo, but
Qualitative and quantitative characterization of protein-phosphoinositide interactions with liposome-based methods
Busse RA, et al.
Autophagy, 9(5), 770-777 (2013)
RIBEYE (B)-domain binds to lipid components of synaptic vesicles in an NAD (H)-dependent, redox-sensitive manner
Schwarz K and Schmitz F
The Biochemical Journal, 474(7), 1205-1220 (2017)
Arupratan Das et al.
Nature cell biology, 14(3), 304-310 (2012-02-22)
Lipid asymmetry at the plasma membrane is essential for such processes as cell polarity, cytokinesis and phagocytosis. Here we find that a lipid flippase complex, composed of Lem3, Dnf1 or Dnf2, has a role in the dynamic recycling of the
Gillian L Dornan et al.
Structure (London, England : 1993), 28(2), 145-156 (2019-12-14)
The class I phosphoinositide 3-kinases (PI3Ks) are key signaling enzymes composed of a heterodimer of a p110 catalytic subunit and a p85 regulatory subunit, with PI3K mutations being causative of multiple human diseases including cancer, primary immunodeficiencies, and developmental disorders.
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.